Pregnancy Clinical Trial
Official title:
Impact of Particulate Matter on Mothers and Babies in Antwerp (IPANEMA), a Prospective Cohort Study on the Impact of Pollutants and Particulate Matter in Pregnancy: Methodology and Design
Introduction: An emerging body of evidence indicates that there is an association between
air pollution exposure in pregnancy and adverse pregnancy outcomes (Rudra, Williams,
Sheppard , Koenig, & Schiff, 2011; Dadvand, et al., 2013; Ritz, et al., 2014). Adverse
pregnancy outcomes tend to lead to adverse neonatal outcome and a higher economic cost.
Epidemiologic studies have also revealed that cardiovascular complications during pregnancy,
such als preeclampsia, are associated with a greater cardiovascular risk during later life (
Abramson & Melvin, 2014).
Aim: This study wants to examine the effects of exposure to environmental factors, polluents
and particulate matter on the clinical pregnancy outcome for mother and child and to
determine which biochemical changes in maternal, placental and cord blood best explain this
effect.
Methods: This study will be performed in a prospective cohort setup (n=200), recruited from
the prenatal clinic in the University Hospital Antwerp. The data collection consists of four
questionnaires (intake, both urine samples and postpartum), two blood samples (28 weeks and
post-partum), two urine samples (20 and 30 weeks), two hair samples (20 weeks and
post-partum), cord blood and the placenta.
Results and conclusion: As the study will start in November 2014, no results are available
yet.
Blood collections (maternal and umbilical cord) Venous blood is drawn around 24 weeks of
gestational age.
Table 1 Tests on maternal blood sample:Routine blood sampling (UZA) Urea, Creatinin, CRP,
LDH, AST, ALT, Uric acid, APTT, PT, Fibrinogen, D-dimers, Glucose, Erythrocytes/hematocrit,
Hemoglobin, Thrombocytes, Leukocytes, Ferritin, Toxoplasmosis (IgG & IgM), CMV (IgG & IgM),
Herpes simplex IgG, Varicella zoster IgG, Rubella IgG, Parvovirus (IgG & IgM), Syphilis (RPR
& TPHAM), Indirect Coombs AML sFlt-1, PlGF, Cystatin C VITO m(i)RNA expression, telomere
length, DNA methylation
Umbilical cord blood is taken at time of birth. Table 2 Tests on umbilical blood sample VITO
m(i)RNA expression, telomere length, DNA methylation
Urine collections Urine samples are taken by the pregnant women themselves, after a minimum
of 8 hours fasting (morning urine). Samples are handed to the midwife at the antenatal
visit, and placed at -20°C freezer within 12 hours of collection. Analysis will be performed
at the Flemish Institute for Technological Research (VITO).
Two urine samples are collected: at 20 weeks and at 30 weeks gestational age. 8 oxo
deoxyguanosine will be determined in the samples.
Hair collections Hair samples are drawn by the midwife around 24 weeks of gestational age
and three days after delivery. Long periods of stress are associated with increased hair
cortisol concentrations (Stalder & Kirschbaum, 2012). Confounding variables are low maternal
education, season of delivery, smoking during pregnancy and obesity (Braig, et al.,
2015).Titanium scissors are cleaned with denaturated ethanol and the midwife wears
disposable gloves in order to limit contamination. A lock of hair with a thickness of a
match (2 mm) and a length of 4 cm will be taken and put in an envelope. Analysis will be
performed at the University of Southern Denmark.
Collection of particulate matter on bedroom window Participants will be asked to clean their
bedroom window with clear water on the in- and outside around 24 weeks of gestation. A
poster (A4 format) will then be attached to the window to create a standardized area for the
measurement of magnetic particles. After minimal 4 weeks, the area in the poster is cleaned
with a sterile pre-injection swab, on both sides of the window. Swabs are transported in a
plastic bag and the ferro(i)magnetic particulate matter fraction will be quantified by
Saturated Isothermal Remanent Magnetization.
Questionnaires
There are four different questionnaires:
Questionnaire on general habits, socio-economic factors, lifestyle and eating habits A
self-designed questionnaire is used to extensively collect information on ethnic origin and
and education level, on employment, income and work environment, on family history of
diseases and chronic disorders, on eating habits, on previous pregnancies and other habits
(smoking, alcohol consumption).
Questionnaire on lifestyle during previous 3 days A self-designed questionnaire is used to
extensively collect information on contact with possible toxic factors and on eating pattern
of the previous 3 days.
Questionnaire on residential facts A self-designed questionnaire is used to collect
information about the exact location of the bedroom window and other possible factors
influencing concentrations of particulate matter.
Questionnaire on stress factors and birth facts A self-designed questionnaire is used to
extensively collect information on stress levels during pregnancy, on birth facts and on
medication during pregnancy.
Questionnaires will be taken at different visits:< 12 weeks 20 weeks 30 weeks birth
Questionnaire on general habits, socio-economic factors, lifestyle and eating habits
Recruitment Questionnaire on lifestyle during previous 3 days Urine sample 1 Urine sample 2
Questionnaire on residential facts 4-8 weeks prior to visit Questionnaire on stress factors
and birth facts 3 days after birth
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02520687 -
Effects of Dietary Nitrate in Hypertensive Pregnant Women
|
Phase 1 |